31/03/2020
2020-03-31
false
false
false
false
true
false
false
false
false
false
false
false
false
true
false
false
true
false
false
false
false
false
false
false
No description of principal activities is disclosed
2019-04-01
Sage Accounts Production 19.0 - FRS102_2019
xbrli:pure
xbrli:shares
iso4217:GBP
08384847
2019-04-01
2020-03-31
08384847
2020-03-31
08384847
2019-03-31
08384847
2018-04-01
2019-03-31
08384847
2019-03-31
08384847
2018-03-31
08384847
core:NetGoodwill
2019-04-01
2020-03-31
08384847
core:Subsidiary1
2019-04-01
2020-03-31
08384847
core:LandBuildings
core:OwnedOrFreeholdAssets
2019-04-01
2020-03-31
08384847
core:FurnitureFittingsToolsEquipment
2019-04-01
2020-03-31
08384847
core:MotorVehicles
2019-04-01
2020-03-31
08384847
core:OnerousContractsExcludingVacantProperties
2019-04-01
2020-03-31
08384847
bus:RegisteredOffice
2019-04-01
2020-03-31
08384847
bus:OrdinaryShareClass1
2019-04-01
2020-03-31
08384847
bus:LeadAgentIfApplicable
2019-04-01
2020-03-31
08384847
bus:Director1
2019-04-01
2020-03-31
08384847
bus:Director2
2019-04-01
2020-03-31
08384847
bus:Director3
2019-04-01
2020-03-31
08384847
bus:Director4
2019-04-01
2020-03-31
08384847
core:WithinOneYear
2020-03-31
08384847
core:WithinOneYear
2019-03-31
08384847
core:NetGoodwill
2019-03-31
08384847
core:NetGoodwill
2020-03-31
08384847
core:LandBuildings
core:OwnedOrFreeholdAssets
2019-03-31
08384847
core:FurnitureFittingsToolsEquipment
2019-03-31
08384847
core:MotorVehicles
2019-03-31
08384847
core:LandBuildings
core:OwnedOrFreeholdAssets
2020-03-31
08384847
core:FurnitureFittingsToolsEquipment
2020-03-31
08384847
core:MotorVehicles
2020-03-31
08384847
core:AfterOneYear
2020-03-31
08384847
core:AfterOneYear
2019-03-31
08384847
core:RetainedEarningsAccumulatedLosses
2018-04-01
2019-03-31
08384847
core:RetainedEarningsAccumulatedLosses
2019-04-01
2020-03-31
08384847
core:UKTax
2019-04-01
2020-03-31
08384847
core:UKTax
2018-04-01
2019-03-31
08384847
bus:AllOrdinaryShares
2019-04-01
2020-03-31
08384847
bus:AllOrdinaryShares
2018-04-01
2019-03-31
08384847
core:ShareCapital
2020-03-31
08384847
core:ShareCapital
2019-03-31
08384847
core:RetainedEarningsAccumulatedLosses
2020-03-31
08384847
core:RetainedEarningsAccumulatedLosses
2019-03-31
08384847
core:ShareCapital
2018-03-31
08384847
core:RetainedEarningsAccumulatedLosses
2018-03-31
08384847
bus:OrdinaryShareClass1
core:ShareCapital
2020-03-31
08384847
bus:OrdinaryShareClass1
core:ShareCapital
2019-03-31
08384847
core:BetweenOneFiveYears
2020-03-31
08384847
core:BetweenOneFiveYears
2019-03-31
08384847
core:FinancialAssetsAmortisedCost
2020-03-31
08384847
core:FinancialAssetsAmortisedCost
2019-03-31
08384847
core:FinancialLiabilitiesAmortisedCost
2020-03-31
08384847
core:FinancialLiabilitiesAmortisedCost
2019-03-31
08384847
core:DeferredTaxation
2019-04-01
2020-03-31
08384847
core:NetGoodwill
2019-03-31
08384847
core:CostValuation
core:Non-currentFinancialInstruments
2020-03-31
08384847
core:Non-currentFinancialInstruments
2020-03-31
08384847
core:Non-currentFinancialInstruments
2019-03-31
08384847
core:AcceleratedTaxDepreciationDeferredTax
2020-03-31
08384847
core:AcceleratedTaxDepreciationDeferredTax
2019-03-31
08384847
core:LandBuildings
core:OwnedOrFreeholdAssets
2019-03-31
08384847
core:FurnitureFittingsToolsEquipment
2019-03-31
08384847
core:MotorVehicles
2019-03-31
08384847
core:FurnitureFittingsToolsEquipment
core:LeasedAssetsHeldAsLessee
2020-03-31
08384847
core:LeasedAssetsHeldAsLessee
core:MotorVehicles
2020-03-31
08384847
core:FurnitureFittingsToolsEquipment
core:LeasedAssetsHeldAsLessee
2019-03-31
08384847
core:LeasedAssetsHeldAsLessee
core:MotorVehicles
2019-03-31
08384847
core:DeferredTaxation
2019-03-31
08384847
core:DeferredTaxation
2020-03-31
08384847
bus:Director1
2019-03-31
08384847
bus:Director1
2020-03-31
08384847
bus:Director2
2019-03-31
08384847
bus:Director2
2020-03-31
08384847
bus:Director3
2019-03-31
08384847
bus:Director3
2020-03-31
08384847
bus:Director4
2019-03-31
08384847
bus:Director4
2020-03-31
08384847
bus:Director1
2018-03-31
08384847
bus:Director1
2019-03-31
08384847
bus:Director2
2018-03-31
08384847
bus:Director2
2019-03-31
08384847
bus:Director3
2018-03-31
08384847
bus:Director3
2019-03-31
08384847
bus:Director4
2018-03-31
08384847
bus:Director4
2019-03-31
08384847
bus:Director1
2018-04-01
2019-03-31
08384847
bus:Director2
2018-04-01
2019-03-31
08384847
bus:Director3
2018-04-01
2019-03-31
08384847
bus:Director4
2018-04-01
2019-03-31
08384847
bus:FRS102
2019-04-01
2020-03-31
08384847
bus:Audited
2019-04-01
2020-03-31
08384847
bus:FullAccounts
2019-04-01
2020-03-31
08384847
bus:LargeMedium-sizedCompaniesRegimeForAccounts
2019-04-01
2020-03-31
08384847
bus:PrivateLimitedCompanyLtd
2019-04-01
2020-03-31
08384847
core:OtherRelatedParties
2019-04-01
2020-03-31
08384847
core:OtherRelatedParties
2018-04-01
2019-03-31
08384847
core:OfficeEquipment
2019-04-01
2020-03-31
08384847
core:OfficeEquipment
2019-03-31
08384847
core:OfficeEquipment
2020-03-31
08384847
core:OtherRelatedParties
2019-03-31
Company registration number:
08384847
Eastern Healthcare Limited
Financial statements
31 March 2020
Eastern Healthcare Limited
Contents
Directors and other information
Strategic report
Directors report
Independent auditor's report to the members
Statement of comprehensive income
Statement of financial position
Statement of changes in equity
Statement of cash flows
Notes to the financial statements
Eastern Healthcare Limited
Directors and other information
|
|
|
|
Directors
|
Mr J Chong
|
|
|
Dr P D J Premachandra
|
|
|
Mrs N Chong
|
|
|
Mrs W Premachandra
|
|
|
|
|
|
|
|
Company number
|
08384847
|
|
|
|
|
|
|
|
Registered office
|
15 Romany Road
|
|
|
Lowestoft
|
|
|
Suffolk
|
|
|
NR32 3PJ
|
|
|
|
|
|
|
|
Business address
|
61 Blyford Road
|
|
|
Lowestoft
|
|
|
Suffolk
|
|
|
NR32 4PZ
|
|
|
|
|
|
|
|
Auditor
|
Lovewell Blake LLP
|
|
|
Excelsior House
|
|
|
9 Quay View Business Park Barnards Way
|
|
|
Lowestoft
|
|
|
Suffolk
|
|
|
NR32 2HD
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bankers
|
Natwest
|
|
|
Norwich City Office
|
|
|
45 London Street
|
|
|
Norwich
|
|
|
Norfolk
|
|
|
NR2 1HX
|
|
|
|
Eastern Healthcare Limited
Strategic report
Year ended 31 March 2020
In the following paragraphs we aim to present a balanced and comprehensive review of the development and performance of our business during the year and its position at the year end. The company currently operates three care homes in Norfolk and Suffolk providing 24 hour care and support for people suffering from dementia and other mental health conditions.
During the financial year the company started work on a new purpose built 9 bed extension at Blyford Residential Home and also started major improvement and development work at The Hollies, this will greatly improve the facilities at this home. Both projects were delayed by two months due to COVID-19 however these are well underway again and are due to complete in August/September of this year.
The Key Performance Indicators (KPIs) for the Company are occupancy rates and turnover and we continue to perform well against both of these. Occupancy has continued to improve in the current year, and has increased from 88% in 2019 to 93%. Turnover has remained consistent with the previous year (2019: £3,942,890 vs 2020 £3,934,417).
The population in the UK is ageing therefore this provides a good foundation for the business to continue to grow and meet our KPI targets, however our main objective is to provide a high level of person centred care and help to the people in our care homes.
The main risks to the business include the implications of failing to meet the high standards demanded by the regulatory environment, limited fee growth from local authorities and from cost increases mainly due to the introduction of the living wage which has pushed up wage costs and will continue to do so in the foreseeable future.
In order to combat these risks as a company we ensure that we have robust governance measures in place and invest in good quality staff. To mitigate the risk of increasing costs and low fee growth from local authority our strategy will continue to be to invest in the each of the homes and maintain them to an excellent standard in order to attract privately funded clientele. As a company we consider the risk imposed by the impending Brexit to be minimal.
As you would expect, we have had considerable challenges since the year end as a result of the Covid-19 pandemic with the impact on our industry sector being enormous. We have worked closely with our customers and their families, as well as CQC, to ensure a safe environment at our homes and to reduce the risks as far as possible.
This report was approved by the board of directors on 28 October 2020 and signed on behalf of the board by:
Dr P D J Premachandra
Director
Eastern Healthcare Limited
Directors report
Year ended 31 March 2020
The directors present their report and the financial statements of the company for the year ended 31 March 2020.
Directors
The directors who served the company during the year were as follows:
|
Mr J Chong
|
Dr P D J Premachandra
|
Mrs N Chong
|
Mrs W Premachandra
|
|
Dividends
Particulars of recommended dividends are detailed in note 11 to the financial statements.
Directors responsibilities statement
The directors are responsible for preparing the strategic report, directors report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period.
In preparing these financial statements, the directors are required to:
-
select suitable accounting policies and then apply them consistently;
-
make judgments and accounting estimates that are reasonable and prudent; and
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Auditor
Each of the persons who is a director at the date of approval of this report confirms that:
-
so far as they are aware, there is no relevant audit information of which the company's auditor is unaware; and - they have taken all steps that they ought to have taken as a director to make themselves aware of any relevant audit information and to establish that the company's auditor is aware of that information.
The auditor is deemed to have been re-appointed in accordance with section 487 of the Companies Act 2006.
This report was approved by the board of directors on
28 October 2020
and signed on behalf of the board by:
Dr P D J Premachandra
Director
Eastern Healthcare Limited
Independent auditor's report to the members of
Eastern Healthcare Limited
Year ended 31 March 2020
Opinion
We have audited the financial statements of Eastern Healthcare Limited (the 'company') for the year ended 31 March 2020 which comprise the statement of comprehensive income, statement of financial position, statement of changes in equity, statement of cash flows and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice). In our opinion, the financial statements: - give a true and fair view of the state of the company's affairs as at 31 March 2020 and of its profit for the year then ended; - have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and - have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
We have nothing to report in respect of the following matters in relation to which the ISAs (UK) require us to report to you where:
-
the directors' use of the going concern basis of accounting in the preparation of the financial statements is not appropriate; or
-
the directors have not disclosed in the financial statements any identified material uncertainties that may cast significant doubt about the company’s ability to continue to adopt the going concern basis of accounting for a period of at least twelve months from the date when the financial statements are authorised for issue.
Other Information
The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
-
the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
-
the strategic report and the directors' report has been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report. We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion: - adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or - the financial statements are not in agreement with the accounting records and the returns; or - certain disclosures of directors' remuneration specified by law are not made; or - we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. As part of an audit in accordance with ISAs (UK), we exercise professional judgment and maintain professional scepticism throughout the audit. we also: - Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. - Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the internal control. - Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the directors. - Conclude on the appropriateness of the directors use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the company to cease to continue as a going concern. - Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation. We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditors report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Mr G Flatt ACA FCCA
(Senior Statutory Auditor)
For and on behalf of
Lovewell Blake LLP
Excelsior House
9 Quay View Business Park Barnards Way
Lowestoft
Suffolk
NR32 2HD
02 November 2020
Eastern Healthcare Limited
Statement of comprehensive income
Year ended 31 March 2020
|
|
|
|
2020
|
|
2019
|
|
|
|
|
Note
|
|
£
|
|
£
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Turnover
|
|
4
|
|
3,934,417
|
|
3,942,890
|
|
|
Cost of sales
|
|
|
|
(
2,838,204)
|
|
(
3,206,687)
|
|
|
|
|
|
|
_______
|
|
_______
|
|
|
Gross profit
|
|
|
|
1,096,213
|
|
736,203
|
|
|
|
|
|
|
|
|
|
|
|
Administrative expenses
|
|
|
|
(
532,567)
|
|
(
466,979)
|
|
|
|
|
|
|
_______
|
|
_______
|
|
|
Operating profit
|
|
5
|
|
563,646
|
|
269,224
|
|
|
|
|
|
|
|
|
|
|
|
Income from participating interests
|
|
7
|
|
73,000
|
|
12,774
|
|
|
Other interest receivable and similar income
|
|
8
|
|
2,856
|
|
2,691
|
|
|
Interest payable and similar expenses
|
|
9
|
|
(
118,563)
|
|
(
118,356)
|
|
|
Profit before taxation
|
|
|
|
520,939
|
|
166,333
|
|
|
|
|
|
|
|
|
|
|
|
Tax on profit
|
|
10
|
|
(
129,214)
|
|
(
72,988)
|
|
|
|
|
|
|
_______
|
|
_______
|
|
|
Profit for the financial year and total comprehensive income
|
|
|
|
391,725
|
|
93,345
|
|
|
|
|
|
|
_______
|
|
_______
|
|
|
|
|
|
|
|
|
|
|
|
All the activities of the company are from continuing operations.
Eastern Healthcare Limited
Statement of financial position
31 March 2020
|
|
|
2020
|
|
|
|
2019
|
|
|
|
|
Note
|
£
|
|
£
|
|
£
|
|
£
|
|
|
|
|
|
|
|
|
|
|
Fixed assets
|
|
|
|
|
|
|
|
|
|
Intangible assets
|
|
12
|
1,195,023
|
|
|
|
1,436,266
|
|
|
Tangible assets
|
|
13
|
4,188,064
|
|
|
|
3,789,410
|
|
|
Investments
|
|
14
|
18,000
|
|
|
|
18,000
|
|
|
|
|
|
_______
|
|
|
|
_______
|
|
|
|
|
|
|
|
5,401,087
|
|
|
|
5,243,676
|
|
|
|
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
|
|
|
|
Stocks
|
|
15
|
3,338
|
|
|
|
3,864
|
|
|
Debtors
|
|
16
|
149,118
|
|
|
|
127,697
|
|
|
Cash at bank and in hand
|
|
|
480,164
|
|
|
|
456,836
|
|
|
|
|
|
_______
|
|
|
|
_______
|
|
|
|
|
|
632,620
|
|
|
|
588,397
|
|
|
Creditors: amounts falling due
|
|
|
|
|
|
|
|
|
|
within one year
|
|
17
|
(
572,885)
|
|
|
|
(
621,605)
|
|
|
|
|
|
_______
|
|
|
|
_______
|
|
|
Net current assets/(liabilities)
|
|
|
|
|
59,735
|
|
|
|
(
33,208)
|
|
|
|
|
|
_______
|
|
|
|
_______
|
Total assets less current liabilities
|
|
|
|
|
5,460,822
|
|
|
|
5,210,468
|
|
|
|
|
|
|
|
|
|
|
Creditors: amounts falling due
|
|
|
|
|
|
|
|
|
|
after more than one year
|
|
18
|
|
|
(
3,508,865)
|
|
|
|
(
3,531,266)
|
|
|
|
|
|
|
|
|
|
|
Provisions for liabilities
|
|
20
|
|
|
(
148,980)
|
|
|
|
(
150,866)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
_______
|
|
|
|
_______
|
Net assets
|
|
|
|
|
1,802,977
|
|
|
|
1,528,336
|
|
|
|
|
|
_______
|
|
|
|
_______
|
|
|
|
|
|
|
|
|
|
|
Capital and reserves
|
|
|
|
|
|
|
|
|
|
Called up share capital
|
|
24
|
|
|
100
|
|
|
|
100
|
Profit and loss account
|
|
25
|
|
|
1,802,877
|
|
|
|
1,528,236
|
|
|
|
|
|
_______
|
|
|
|
_______
|
Shareholders funds
|
|
|
|
|
1,802,977
|
|
|
|
1,528,336
|
|
|
|
|
|
_______
|
|
|
|
_______
|
|
|
|
|
|
|
|
|
|
|
These financial statements were approved by the
board of directors
and authorised for issue on
28 October 2020
, and are signed on behalf of the board by:
Mr J Chong
Director
Company registration number:
08384847
Eastern Healthcare Limited
Statement of changes in equity
Year ended 31 March 2020
|
|
Called up share capital
|
|
Profit and loss account
|
Total
|
|
|
|
|
|
|
|
£
|
|
£
|
£
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At 1 April 2018
|
|
100
|
|
1,497,491
|
1,497,591
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Profit for the year
|
|
|
|
93,345
|
93,345
|
|
|
|
|
|
|
|
_______
|
|
_______
|
_______
|
|
|
|
|
|
Total comprehensive income for the year
|
|
-
|
|
93,345
|
93,345
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid and payable
|
|
|
|
(
62,600)
|
(
62,600)
|
|
|
|
|
|
|
|
_______
|
|
_______
|
_______
|
|
|
|
|
|
Total investments by and distributions to owners
|
|
-
|
|
(
62,600)
|
(
62,600)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
_______
|
|
_______
|
_______
|
|
|
|
|
|
At 31 March 2019 and 1 April 2019
|
|
100
|
|
1,528,236
|
1,528,336
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Profit for the year
|
|
|
|
391,725
|
391,725
|
|
|
|
|
|
|
|
_______
|
|
_______
|
_______
|
|
|
|
|
|
Total comprehensive income for the year
|
|
-
|
|
391,725
|
391,725
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid and payable
|
|
|
|
(
117,084)
|
(
117,084)
|
|
|
|
|
|
|
|
_______
|
|
_______
|
_______
|
|
|
|
|
|
Total investments by and distributions to owners
|
|
-
|
|
(
117,084)
|
(
117,084)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
_______
|
|
_______
|
_______
|
|
|
|
|
|
At 31 March 2020
|
|
100
|
|
1,802,877
|
1,802,977
|
|
|
|
|
|
|
|
_______
|
|
_______
|
_______
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Eastern Healthcare Limited
Statement of cash flows
Year ended 31 March 2020
|
|
2020
|
|
2019
|
|
|
|
£
|
|
£
|
|
|
|
|
|
|
|
Cash flows from operating activities
|
|
|
|
|
|
Profit for the financial year
|
|
391,725
|
|
93,345
|
|
|
|
|
|
|
|
Adjustments for:
|
|
|
|
|
|
Depreciation of tangible assets
|
|
152,921
|
|
135,167
|
|
Amortisation of intangible assets
|
|
241,243
|
|
241,243
|
|
Income from participating interests
|
|
(
73,000)
|
|
(
12,774)
|
|
Other interest receivable and similar income
|
|
(
2,856)
|
|
(
2,691)
|
|
Interest payable and similar expenses
|
|
118,563
|
|
118,356
|
|
Gain/(loss) on disposal of tangible assets
|
|
1,712
|
|
262
|
|
Tax on profit
|
|
129,214
|
|
72,988
|
|
Accrued expenses/(income)
|
|
(
7,426)
|
|
(
6,127)
|
|
|
|
|
|
|
|
Changes in:
|
|
|
|
|
|
Stocks
|
|
526
|
|
(
1,053)
|
|
Trade and other debtors
|
|
(
15,998)
|
|
8,013
|
|
Trade and other creditors
|
|
148,056
|
|
(
34,592)
|
|
|
|
_______
|
|
_______
|
|
Cash generated from operations
|
|
1,084,680
|
|
612,137
|
|
|
|
|
|
|
|
Interest paid
|
|
(
118,563)
|
|
(
118,356)
|
|
Interest received
|
|
2,856
|
|
2,691
|
|
Tax paid
|
|
(
54,243)
|
|
(
95,458)
|
|
|
|
_______
|
|
_______
|
|
Net cash from operating activities
|
|
914,730
|
|
401,014
|
|
|
|
_______
|
|
_______
|
|
|
|
|
|
|
|
Cash flows from investing activities
|
|
|
|
|
|
Purchase of tangible assets
|
|
(
553,387)
|
|
(
170,382)
|
|
Proceeds from sale of tangible assets
|
|
100
|
|
5,534
|
|
Dividends received
|
|
73,000
|
|
12,774
|
|
|
|
_______
|
|
_______
|
|
Net cash used in investing activities
|
|
(
480,287)
|
|
(
152,074)
|
|
|
|
_______
|
|
_______
|
|
|
|
|
|
|
|
Cash flows from financing activities
|
|
|
|
|
|
Proceeds from issue of shares classed as financial liabilities
|
|
-
|
|
(500,000)
|
|
Proceeds from borrowings
|
|
(
281,801)
|
|
404,583
|
|
Payment of finance lease liabilities
|
|
(
12,230)
|
|
(
8,562)
|
|
Equity dividends paid
|
|
(
117,084)
|
|
(
62,600)
|
|
|
|
_______
|
|
_______
|
|
Net cash used in financing activities
|
|
(
411,115)
|
|
(
166,579)
|
|
|
|
_______
|
|
_______
|
|
|
|
|
|
|
|
Net increase/(decrease) in cash and cash equivalents
|
|
23,328
|
|
82,361
|
|
Cash and cash equivalents at beginning of year
|
|
456,836
|
|
374,475
|
|
|
|
_______
|
|
_______
|
|
Cash and cash equivalents at end of year
|
|
480,164
|
|
456,836
|
|
|
|
_______
|
|
_______
|
|
|
|
|
|
|
|
Eastern Healthcare Limited
Notes to the financial statements
Year ended 31 March 2020
1.
General information
The company is a private company limited by shares, registered in England. The address of the registered office is 15 Romany Road, Lowestoft, Suffolk, NR32 3PJ.
2.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. The Triennial review 2017 amendments to the standard have been early adopted.
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The financial statements have been prepared on a going concern basis. Although Coronavirus has affected the daily operations of the business, like many others, management are taking all possible steps to mitigate any risk that may affect the company's ability to trade. Management have undertaken detailed planning and cashflow modelling in reaching their view that the going concern basis is appropriate. The company also continues to be profitable throughout the pandemic with positive cashflow.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Goodwill
Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
|
|
|
|
Goodwill |
- |
10 % |
straight line
|
|
|
|
|
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
|
|
|
|
|
|
Freehold property
|
-
|
2 %
|
straight line
|
|
Fittings fixtures and equipment
|
-
|
15 %
|
straight line
|
|
Motor vehicles
|
-
|
25 %
|
straight line
|
|
Office equipment
|
-
|
25 %
|
straight line
|
|
|
|
|
|
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Fixed asset investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.
Hire purchase and finance leases
Assets held under finance leases are recognised in the statement of financial position as assets and liabilities at the lower of the fair value of the assets and the present value of the minimum lease payments, which is determined at the inception of the lease term. Any initial direct costs of the lease are added to the amount recognised as an asset. Lease payments are apportioned between the finance charges and reduction of the outstanding lease liability using the effective interest method. Finance charges are allocated to each period so as to produce a constant rate of interest on the remaining balance of the liability.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.
4.
Turnover
Turnover arises from:
|
|
|
2020
|
2019
|
|
|
|
£
|
£
|
|
Sale of goods
|
|
3,934,417
|
3,942,890
|
|
|
|
_______
|
_______
|
|
|
|
|
|
The whole of the turnover is attributable to the principal activity of the company wholly undertaken in the United Kingdom.
5.
Operating profit
Operating profit is stated after charging/(crediting):
|
|
|
|
2020
|
2019
|
|
|
|
|
£
|
£
|
|
Amortisation of intangible assets
|
|
|
241,243
|
241,243
|
|
Depreciation of tangible assets
|
|
|
152,921
|
135,167
|
|
(Gain)/loss on disposal of tangible assets
|
|
|
1,712
|
262
|
|
Fees payable for the audit of the financial statements
|
|
|
6,600
|
5,400
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
|
6.
Staff costs
The average number of persons employed by the company during the year, including the directors, amounted to:
|
|
|
2020
|
2019
|
|
Production staff
|
|
170
|
182
|
|
Administrative staff
|
|
1
|
1
|
|
|
|
_______
|
_______
|
|
|
|
171
|
183
|
|
|
|
_______
|
_______
|
|
|
|
|
|
The aggregate payroll costs incurred during the year were:
|
|
|
2020
|
2019
|
|
|
|
£
|
£
|
|
Wages and salaries
|
|
2,113,427
|
2,157,393
|
|
Social security costs
|
|
5,663
|
2,849
|
|
Other pension costs
|
|
11,337
|
5,990
|
|
|
|
_______
|
_______
|
|
|
|
2,130,427
|
2,166,232
|
|
|
|
_______
|
_______
|
|
|
|
|
|
7.
Income from participating interests
|
|
|
2020
|
2019
|
|
|
|
£
|
£
|
|
Dividends from participating interests
|
|
73,000
|
12,774
|
|
|
|
_______
|
_______
|
|
|
|
|
|
8.
Other interest receivable and similar income
|
|
|
2020
|
2019
|
|
|
|
£
|
£
|
|
Bank deposits
|
|
2,851
|
2,691
|
|
Other interest receivable and similar income
|
|
5
|
-
|
|
|
|
_______
|
_______
|
|
|
|
2,856
|
2,691
|
|
|
|
_______
|
_______
|
|
|
|
|
|
9.
Interest payable and similar expenses
|
|
|
|
2020
|
2019
|
|
|
|
|
£
|
£
|
|
Bank loans and overdrafts
|
|
|
116,091
|
113,942
|
|
Other loans made to the company:
|
|
|
|
|
|
|
Finance leases and hire purchase contracts
|
|
2,472
|
4,137
|
|
|
Other interest on other loans made to the company
|
|
-
|
277
|
|
|
|
|
_______
|
_______
|
|
|
|
|
118,563
|
118,356
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
|
10.
Tax on profit
Major components of tax expense
|
|
|
2020
|
2019
|
|
|
|
£
|
£
|
|
Current tax:
|
|
|
|
|
UK current tax expense
|
|
131,100
|
54,243
|
|
|
|
_______
|
_______
|
|
|
|
|
|
|
Deferred tax:
|
|
|
|
|
Origination and reversal of timing differences
|
|
(
1,886)
|
18,745
|
|
|
|
_______
|
_______
|
|
Tax on profit
|
|
129,214
|
72,988
|
|
|
|
_______
|
_______
|
|
|
|
|
|
Reconciliation of tax expense
The tax assessed on the profit for the year is higher than (2019: higher than) the
standard rate of corporation tax in the UK
of
19.00
% (2019: 19.00%).
|
|
|
2020
|
2019
|
|
|
|
£
|
£
|
|
Profit before taxation
|
|
520,939
|
166,333
|
|
|
|
_______
|
_______
|
|
|
|
|
|
|
Profit multiplied by rate of tax
|
|
98,978
|
31,603
|
|
Effect of expenses not deductible for tax purposes
|
|
(
195,394)
|
(
96,237)
|
|
Effect of capital allowances and depreciation
|
|
227,516
|
118,877
|
|
Deferred tax
|
|
(1,886)
|
18,745
|
|
|
|
_______
|
_______
|
|
Tax on profit
|
|
129,214
|
72,988
|
|
|
|
_______
|
_______
|
|
|
|
|
|
11.
Dividends
Equity dividends
|
|
|
2020
|
2019
|
|
|
|
£
|
£
|
|
Dividends paid during the year (excluding those for which a liability existed at the end of the prior year)
|
|
117,084
|
62,600
|
|
|
|
_______
|
_______
|
|
|
|
|
|
12.
Intangible assets
|
|
Goodwill
|
Total
|
|
|
|
|
|
|
£
|
£
|
|
|
|
|
|
Cost
|
|
|
|
|
|
|
|
At 1 April 2019 and 31 March 2020
|
2,412,431
|
2,412,431
|
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
Amortisation
|
|
|
|
|
|
|
|
At 1 April 2019
|
976,165
|
976,165
|
|
|
|
|
|
Charge for the year
|
241,243
|
241,243
|
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
At 31 March 2020
|
1,217,408
|
1,217,408
|
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
Carrying amount
|
|
|
|
|
|
|
|
At 31 March 2020
|
1,195,023
|
1,195,023
|
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
At 31 March 2019
|
1,436,266
|
1,436,266
|
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
|
|
|
|
|
|
|
13.
Tangible assets
|
|
Freehold property
|
Fixtures, fittings and equipment
|
Motor vehicles
|
Office equipment
|
Total
|
|
|
|
|
£
|
£
|
£
|
£
|
£
|
|
|
|
Cost
|
|
|
|
|
|
|
|
|
At 1 April 2019
|
3,767,505
|
429,717
|
56,668
|
12,453
|
4,266,343
|
|
|
|
Additions
|
479,361
|
72,723
|
-
|
1,303
|
553,387
|
|
|
|
Disposals
|
-
|
-
|
(
3,000)
|
-
|
(
3,000)
|
|
|
|
|
_______
|
_______
|
_______
|
_______
|
_______
|
|
|
|
At 31 March 2020
|
4,246,866
|
502,440
|
53,668
|
13,756
|
4,816,730
|
|
|
|
|
_______
|
_______
|
_______
|
_______
|
_______
|
|
|
|
Depreciation
|
|
|
|
|
|
|
|
|
At 1 April 2019
|
298,264
|
140,886
|
30,377
|
7,406
|
476,933
|
|
|
|
Charge for the year
|
69,350
|
67,674
|
13,588
|
2,309
|
152,921
|
|
|
|
Disposals
|
-
|
-
|
(
1,188)
|
-
|
(
1,188)
|
|
|
|
|
_______
|
_______
|
_______
|
_______
|
_______
|
|
|
|
At 31 March 2020
|
367,614
|
208,560
|
42,777
|
9,715
|
628,666
|
|
|
|
|
_______
|
_______
|
_______
|
_______
|
_______
|
|
|
|
Carrying amount
|
|
|
|
|
|
|
|
|
At 31 March 2020
|
3,879,252
|
293,880
|
10,891
|
4,041
|
4,188,064
|
|
|
|
|
_______
|
_______
|
_______
|
_______
|
_______
|
|
|
|
At 31 March 2019
|
3,469,241
|
288,831
|
26,291
|
5,047
|
3,789,410
|
|
|
|
|
_______
|
_______
|
_______
|
_______
|
_______
|
|
|
|
|
|
|
|
|
|
|
|
Obligations under finance leases
Included within the carrying value of tangible assets are the following amounts relating to assets held under finance leases or hire purchase agreements:
|
|
|
|
|
|
|
|
|
|
|
Fixtures, fittings and equipment
|
Motor vehicles
|
|
|
|
|
|
|
|
£
|
£
|
|
|
|
|
|
|
At 31 March 2020
|
13,687
|
9,269
|
|
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
|
At 31 March 2019
|
46,532
|
21,420
|
|
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.
Investments
|
|
Shares in group undertakings
|
Total
|
|
|
|
|
|
|
£
|
£
|
|
|
|
|
|
Cost
|
|
|
|
|
|
|
|
At 1 April 2019 and 31 March 2020
|
18,000
|
18,000
|
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
Impairment
|
|
|
|
|
|
|
|
At 1 April 2019 and 31 March 2020
|
-
|
-
|
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
Carrying amount
|
|
|
|
|
|
|
|
At 31 March 2020
|
18,000
|
18,000
|
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
At 31 March 2019
|
18,000
|
18,000
|
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
|
|
|
|
|
|
|
St Edmunds Limited is a wholly owned subsidiary company, incorporated in England. The company has not traded in the financial year and remains dormant.
|
Investments in group undertakings
|
|
|
|
|
|
|
|
Registered office
|
Class of share
|
Percentage of shares held
|
|
Subsidiary undertakings
|
|
|
|
|
|
St Edmunds Ltd
|
|
4-5 Marine Parade, Gorleston, Gt Yarmouth, Norfolk, NR31 6DP
|
Ordinary
|
100
|
|
|
|
|
|
|
|
|
|
|
|
|
The results and capital and reserves for the period of the trading companies are as follows:
|
|
|
|
|
|
|
|
|
Capital and
|
Profit/(loss)
|
|
|
|
|
reserves
|
for the
|
|
|
|
|
|
period
|
|
|
|
2020
|
2019
|
2019
|
|
|
|
£
|
£
|
£
|
|
|
Subsidiary undertakings
|
|
|
|
|
|
St Edmunds Ltd
|
18,000
|
18,000
|
-
|
|
|
|
|
|
|
|
15.
Stocks
|
|
|
2020
|
2019
|
|
|
|
£
|
£
|
|
Finished goods and goods for resale
|
|
3,338
|
3,864
|
|
|
|
_______
|
_______
|
|
|
|
|
|
16.
Debtors
|
|
|
2020
|
2019
|
|
|
|
£
|
£
|
|
Trade debtors
|
|
102,874
|
61,407
|
|
Prepayments and accrued income
|
|
24,525
|
28,152
|
|
Other debtors
|
|
21,719
|
38,138
|
|
|
|
_______
|
_______
|
|
|
|
149,118
|
127,697
|
|
|
|
_______
|
_______
|
|
|
|
|
|
17.
Creditors: amounts falling due within one year
|
|
|
2020
|
2019
|
|
|
|
£
|
£
|
|
Bank loans and overdrafts
|
|
-
|
254,985
|
|
Trade creditors
|
|
193,388
|
63,202
|
|
Accruals and deferred income
|
|
90,485
|
92,272
|
|
Corporation tax
|
|
131,100
|
54,243
|
|
Social security and other taxes
|
|
20,943
|
16,436
|
|
Obligations under finance leases
|
|
22,771
|
12,230
|
|
Director loan accounts
|
|
59,220
|
86,406
|
|
Other creditors
|
|
54,978
|
41,831
|
|
|
|
_______
|
_______
|
|
|
|
572,885
|
621,605
|
|
|
|
_______
|
_______
|
|
|
|
|
|
The company has taken a 12 capital repayment holiday on its bank loans with Natwest, this began on 15 April 2020.
18.
Creditors: amounts falling due after more than one year
|
|
|
2020
|
2019
|
|
|
|
£
|
£
|
|
Bank loans and overdrafts
|
|
3,500,290
|
3,499,920
|
|
Obligations under finance leases
|
|
8,575
|
31,346
|
|
|
|
_______
|
_______
|
|
|
|
3,508,865
|
3,531,266
|
|
|
|
_______
|
_______
|
|
|
|
|
|
Included within creditors: amounts falling due after more than one year is an amount of £ 2,473,147
(2019 £ 2,408,942 ) in respect of liabilities payable or repayable by instalments which fall due for payment after more than five years from the reporting date.
The bank loans are secured by a charge on the properties concerned, they are repayble over a term of 25 years and the rate of interest is 2.51% above the Bank of England Base Rate.
19.
Obligations under finance leases
Company lessee
The total future minimum lease payments under finance lease agreements are as follows:
|
|
|
2020
|
2019
|
|
|
|
£
|
£
|
|
Not later than 1 year
|
|
22,771
|
12,230
|
|
Later than 1 year and not later than 5 years
|
|
8,576
|
31,347
|
|
|
|
_______
|
_______
|
|
|
|
31,347
|
43,577
|
|
|
|
_______
|
_______
|
|
Present value of minimum lease payments
|
|
31,347
|
43,577
|
|
|
|
_______
|
_______
|
|
|
|
|
|
The Hire Purchase agreements are secured on the assets concerned.
20.
Provisions
|
|
Deferred tax (note 21)
|
Total
|
|
|
|
|
|
£
|
£
|
|
|
|
|
At 1 April 2019
|
150,866
|
150,866
|
|
|
|
|
Charges against provisions
|
(
1,886)
|
(
1,886)
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
At 31 March 2020
|
148,980
|
148,980
|
|
|
|
|
|
_______
|
_______
|
|
|
|
|
|
|
|
|
|
|
21.
Deferred tax
The deferred tax included in the statement of financial position is as follows:
|
|
|
2020
|
2019
|
|
|
|
£
|
£
|
|
Included in provisions (note 20)
|
|
148,980
|
150,866
|
|
|
|
_______
|
_______
|
|
|
|
|
|
The deferred tax account consists of the tax effect of timing differences in respect of:
|
|
|
2020
|
2019
|
|
|
|
£
|
£
|
|
Accelerated capital allowances
|
|
148,980
|
150,866
|
|
|
|
_______
|
_______
|
|
|
|
|
|
22.
Employee benefits
The amount recognised in profit or loss in relation to defined contribution plans was £
11,337
(2019: £
5,990
).
23.
Financial instruments
The carrying amount for each category of financial instrument is as follows:
|
|
|
2020
|
2019
|
|
|
|
£
|
£
|
|
Financial assets that are debt instruments measured at amortised cost
|
|
|
|
|
Trade debtors
|
|
102,874
|
61,407
|
|
Other debtors
|
|
21,719
|
38,138
|
|
|
|
_______
|
_______
|
|
|
|
124,593
|
99,545
|
|
|
|
_______
|
_______
|
|
|
|
|
|
|
Financial liabilities measured at amortised cost
|
|
|
|
|
Trade creditors
|
|
193,388
|
63,202
|
|
Accruals
|
|
64,819
|
66,822
|
|
Other creditors
|
|
86,326
|
85,407
|
|
|
|
_______
|
_______
|
|
|
|
344,533
|
215,431
|
|
|
|
_______
|
_______
|
|
|
|
|
|
|
Loan commitments measured at cost less impairment
|
|
|
|
|
Bank loans
|
|
3,500,290
|
3,754,906
|
|
|
|
_______
|
_______
|
|
|
|
|
|
24.
Called up share capital
Issued, called up and fully paid
|
|
|
2020
|
|
|
|
2019
|
|
|
|
|
|
No
|
|
£
|
|
No
|
|
£
|
|
Ordinary
shares of £
1.00 each
|
|
100
|
|
100
|
|
100
|
|
100
|
|
|
|
_______
|
|
_______
|
|
_______
|
|
_______
|
|
|
|
|
|
|
|
|
|
|
25.
Reserves
Profit and loss account - This reserve records retained earnings and accumulated losses.
26.
Analysis of changes in net debt
|
|
At 1 April 2019
|
Cash flows
|
At 31 March 2020
|
|
|
|
|
|
£
|
£
|
£
|
|
|
|
|
Cash and cash equivalents
|
456,836
|
23,328
|
480,164
|
|
|
|
|
Debt due within one year
|
(353,621)
|
271,630
|
(81,991)
|
|
|
|
|
Debt due after one year
|
(3,531,266)
|
22,401
|
(3,508,865)
|
|
|
|
|
|
_______
|
_______
|
_______
|
|
|
|
|
|
(
3,428,051)
|
317,359
|
(
3,110,692)
|
|
|
|
|
|
_______
|
_______
|
_______
|
|
|
|
|
|
|
|
|
|
|
|
27.
Directors advances, credits and guarantees
|
During the year the directors entered into the following advances and credits with the company:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2020
|
|
|
|
|
|
|
|
|
|
Balance brought forward
|
Advances /(credits) to the directors
|
Amounts repaid
|
Balance o/standing
|
|
|
|
|
£
|
£
|
£
|
£
|
|
|
|
Mr J Chong
|
(
28,995)
|
(
83,143)
|
99,432
|
(
12,706)
|
|
|
|
Dr P D J Premachandra
|
(
14,208)
|
(
29,271)
|
26,575
|
(
16,904)
|
|
|
|
Mrs N Chong
|
(
28,995)
|
(
83,143)
|
99,432
|
(
12,706)
|
|
|
|
Mrs W Premachandra
|
(
14,208)
|
(
29,271)
|
26,575
|
(
16,904)
|
|
|
|
|
_______
|
_______
|
_______
|
_______
|
|
|
|
|
(
86,406)
|
(
224,828)
|
252,014
|
(
59,220)
|
|
|
|
|
_______
|
_______
|
_______
|
_______
|
|
|
|
|
|
|
|
|
|
|
2019
|
|
|
|
|
|
|
|
|
|
Balance brought forward
|
Advances /(credits) to the directors
|
Amounts repaid
|
Balance o/standing
|
|
|
|
|
£
|
£
|
£
|
£
|
|
|
|
Mr J Chong
|
(
27,497)
|
(
19,076)
|
17,578
|
(
28,995)
|
|
|
|
Dr P D J Premachandra
|
(
11,709)
|
(
15,650)
|
13,151
|
(
14,208)
|
|
|
|
Mrs N Chong
|
(
27,497)
|
(
19,076)
|
17,578
|
(
28,995)
|
|
|
|
Mrs W Premachandra
|
(
11,709)
|
(
15,650)
|
13,151
|
(
14,208)
|
|
|
|
|
_______
|
_______
|
_______
|
_______
|
|
|
|
|
(
78,412)
|
(
69,452)
|
61,458
|
(
86,406)
|
|
|
|
|
_______
|
_______
|
_______
|
_______
|
|
|
|
|
|
|
|
|
|
|
28.
Related party transactions
During the year the company entered into the following transactions with related parties:
|
|
Transaction value
|
|
Balance owed by/(owed to)
|
|
|
|
2020
|
2019
|
2020
|
2019
|
|
|
£
|
£
|
£
|
£
|
|
Saturn Healthcare Limited
|
-
|
15,000
|
-
|
15,000
|
|
|
_______
|
_______
|
_______
|
_______
|
|
|
|
|
|
|
29.
Controlling party
Eastern Healthcare Ltd is the 100% wholly owned subsidiary of its ultimate parent company, Eastern Healthcare (Holdings) Ltd.